Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2022 | 2 |
2023 | 2 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Cost-effectiveness analysis of sorafenib, lenvatinib, atezolizumab plus bevacizumab and sintilimab plus bevacizumab for the treatment of advanced hepatocellular carcinoma in China.
Cost Eff Resour Alloc. 2023 Mar 31;21(1):20. doi: 10.1186/s12962-023-00435-x.
Cost Eff Resour Alloc. 2023.
PMID: 37004046
Free PMC article.
Narciclasine, a novel topoisomerase I inhibitor, exhibited potent anti-cancer activity against cancer cells.
Wang M, Liang L, Wang R, Jia S, Xu C, Wang Y, Luo M, Lin Q, Yang M, Zhou H, Liu D, Qing C.
Wang M, et al.
Nat Prod Bioprospect. 2023 Aug 29;13(1):27. doi: 10.1007/s13659-023-00392-1.
Nat Prod Bioprospect. 2023.
PMID: 37640882
Free PMC article.
Item in Clipboard
Synthesis and anticancer activity of two highly water-soluble and ionic Pt(iv) complexes as prodrugs for Pt(ii) anticancer drugs.
Gao A, Wu Y, Yu J, Gong H, Jiang J, Yang C, Liu W, Qing C.
Gao A, et al.
RSC Med Chem. 2022 Mar 18;13(5):594-598. doi: 10.1039/d2md00004k. eCollection 2022 May 25.
RSC Med Chem. 2022.
PMID: 35694692
Free PMC article.
Item in Clipboard
9-Nitro-20(S)-carbonate-camptothecin (NCP4), a novel prodrug of 9-nitrocamptothecin (9-NC), exhibits potent chemotherapeutic efficacy and improved safety against hepatocarcinoma.
Zhou H, Zhang Y, Tian Y, Sun Y, Chen Y, Zhang Y, Zhu Q, Pan J, Qing C.
Zhou H, et al.
Eur J Pharmacol. 2022 May 15;923:174898. doi: 10.1016/j.ejphar.2022.174898. Epub 2022 Mar 17.
Eur J Pharmacol. 2022.
PMID: 35305999
Item in Clipboard
Next-generation sequencing-based genomic profiling analysis reveals novel mutations for clinical diagnosis in Chinese primary epithelial ovarian cancer patients.
Zhang L, Luo M, Yang H, Zhu S, Cheng X, Qing C.
Zhang L, et al.
J Ovarian Res. 2019 Feb 20;12(1):19. doi: 10.1186/s13048-019-0494-4.
J Ovarian Res. 2019.
PMID: 30786925
Free PMC article.
Item in Clipboard
Cite
Cite